Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV
Author:
Affiliation:
1. School of Biomedical Sciences, University of Queensland, St Lucia, Australia
Funder
National Health and Medical Research Council
Publisher
Informa UK Limited
Subject
Cell Biology,Cellular and Molecular Neuroscience
Link
https://www.tandfonline.com/doi/pdf/10.1080/19336918.2019.1710015
Reference38 articles.
1. Gene Expression Profiling: Changing Face of Breast Cancer Classification and Management
2. Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms
3. Genes and functions from breast cancer signatures
4. Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance
5. Knockout of human arylamine N ‐acetyltransferase 1 (NAT1) in MDA‐MB‐231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Arylamine N-Acetyltransferases;Reference Module in Biomedical Sciences;2024
2. The arylamine N-acetyltransferases as therapeutic targets in metabolic diseases associated with mitochondrial dysfunction.;Pharmacological Reviews;2023-12-07
3. Stable Isotope Tracing Reveals an Altered Fate of Glucose in N-Acetyltransferase 1 Knockout Breast Cancer Cells;Genes;2023-03-31
4. Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis;Breast Cancer Research and Treatment;2022-08-02
5. Deletion of arylamine N ‐acetyltransferase 1 in MDA‐MB‐231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis;Molecular Carcinogenesis;2022-02-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3